PharmaCielo Signs Sales Agreement With Brazilian Phyto-Therapeutic Company

PharmaCielo Ltd. (OTCQX: PCLOF) (TSXV:PCLO) , the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade extracts, PharmaCielo Colombia Holdings S.A.S., entered into a supply agreement with one of the largest phyto-therapeutic companies in the Brazilian market. The customer has an extensive distribution network across Latin America, and is also a certified B-Corp, reflecting its commitment to a transparent business model that measures social and environmental impacts.

PharmaCielo will be registered with Anvisa as the sole supplier to the customer for this product, and under the agreement, PharmaCielo will ship significant quarterly volumes of a …

Full story available on Benzinga.com

PharmaCielo Signs Sales Agreement With Brazilian Phyto-Therapeutic Company on Benzinga